74 results
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
). Following the Closing Date, Mayne may use its trade name on any packaging, leaflets, advertising, or promotional materials used for or in connection … with the Marked Product(s). Effective as of the date on which Mayne changes any packaging leaflets, advertising, or promotional materials used
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
or to regulatory approvals, investigational exemptions, or the procurement, development, research, manufacture, production, packaging, labeling, distribution … ) intermediates, (c) excipients, (d) processing aids, (e) active ingredients, (f) bulk drug product, and (g) packaging and labelling materials and components
8-K
EX-2.1
TXMD
TherapeuticsMD Inc
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
, packaging, good manufacturing practices, labeling, advertising, promotional practices, safety surveillance, record keeping and filing of required reports
8-K
EX-2.1
oxnx69
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
S-3ASR
EX-1.2
8ect8gj0v6hbup2eqa
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-1.1
59y6n1x5
16 Feb 21
Entry into a Material Definitive Agreement
8:35am
8-K
EX-99.1
nkoyfloco2a d7nfu
13 Jan 21
Entry into a Material Definitive Agreement
8:50am
8-K
EX-1.1
8q7o6m4
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-1.1
of23b6fc3 cnl
13 Nov 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
z0pgezlv2pymjm8 v9rs
14 Sep 20
Regulation FD Disclosure
6:30am
8-K
EX-99.1
1nr1ndmp uzydaokgq9u
23 Jun 20
Regulation FD Disclosure
6:51am
8-K
EX-99.1
o333dnbu9gkzcxhf
13 May 20
Regulation FD Disclosure
7:07am